webinar register page

Topic

N=1 Collaborative Seminar Series - Feb 13

Description

The most important aspects of the guidelines for N=1 exon skipping design and in vitro development by Annemieke Aartsma-Rus

Time

Feb 13, 2023 10:30 AM in Eastern Time (US and Canada)

* Required information

Speakers

Annemieke Aartsma-Rus, PhD

@Dutch Center for RNA Therapeutics

Prof. Dr. Annemieke Aartsma-Rus is a professor of Translational Genetics at the Department of Human Genetics of the Leiden University Medical Center. She played an important role in the development of antisense mediated exon skipping for Duchenne muscular dystrophy during her PhD research (2000-2004) at the Leiden University Medical Center (the Netherlands). As of December 2007 she became leader of the “DMD exon skip group”. Since 2013 she has a visiting professorship at the Institute of Genetic Medicine of Newcastle University (UK). In 2020 she co-founded the Dutch Center for RNA Therapeutics (DCRT), a not-for-profit academic collaboration aiming to develop clinical treatment with exon skipping therapies for eligible patients with unique mutations.

Time Zone:

Your Information
Send to
Message preview	Hi there, You are invited to a Zoom webinar. When: Feb 13, 2023 10:30 AM Eastern Time (US and Canada) Topic: N=1 Collaborative Seminar Series - Feb 13 Register in advance for this webinar: https://us06web.zoom.us/webinar/register/WN_FBxbxWq5Q_SMv1oImi6L-g After registering, you will receive a confirmation email containing information about joining the webinar. ---------- Webinar Speakers Annemieke Aartsma-Rus, PhD (@Dutch Center for RNA Therapeutics) Prof. Dr. Annemieke Aartsma-Rus is a professor of Translational Genetics at the Department of Human Genetics of the Leiden University Medical Center. She played an important role in the development of antisense mediated exon skipping for Duchenne muscular dystrophy during her PhD research (2000-2004) at the Leiden University Medical Center (the Netherlands). As of December 2007 she became leader of the “DMD exon skip group”. Since 2013 she has a visiting professorship at the Institute of Genetic Medicine of Newcastle University (UK). In 2020 she co-founded the Dutch Center for RNA Therapeutics (DCRT), a not-for-profit academic collaboration aiming to develop clinical treatment with exon skipping therapies for eligible patients with unique mutations.

webinar register page

Webinar Registration

Speakers

Share via Email

Switch Time Zone

Upcoming Meetings